These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29137280)

  • 1. PPARγ sumoylation-mediated lipid accumulation in lung cancer.
    Phan ANH; Vo VTA; Hua TNM; Kim MK; Jo SY; Choi JW; Kim HW; Son J; Suh YA; Jeong Y
    Oncotarget; 2017 Oct; 8(47):82491-82505. PubMed ID: 29137280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
    Kim J; Sato M; Choi JW; Kim HW; Yeh BI; Larsen JE; Minna JD; Cha JH; Jeong Y
    PLoS One; 2015; 10(8):e0134842. PubMed ID: 26244663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G; Bellanti F; Vendemiale G
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent trends in PPARgamma agonist development of thiazolidinediones and non-thiazolidinediones].
    Tanaka T
    Nihon Rinsho; 2010 Feb; 68(2):249-55. PubMed ID: 20158092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
    Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.
    Yang C; Jo SH; Csernus B; Hyjek E; Liu Y; Chadburn A; Wang YL
    Am J Pathol; 2007 Feb; 170(2):722-32. PubMed ID: 17255338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of PPARgamma agonist on dyslipidemia and atherosclerosis].
    Komatsu A; Node K
    Nihon Rinsho; 2010 Feb; 68(2):294-8. PubMed ID: 20158099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
    Kim KY; Ahn JH; Cheon HG
    Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
    Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
    Wang M; Tafuri S
    J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.
    Cha BS; Ciaraldi TP; Park KS; Carter L; Mudaliar SR; Henry RR
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E151-9. PubMed ID: 15727952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome Proliferator-Activated Receptor γ Regulates Chronic Alcohol-Induced Alveolar Macrophage Dysfunction.
    Yeligar SM; Mehta AJ; Harris FL; Brown LA; Hart CM
    Am J Respir Cell Mol Biol; 2016 Jul; 55(1):35-46. PubMed ID: 26677910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra.
    Whitehead JP
    Int J Biochem Cell Biol; 2011 Aug; 43(8):1071-4. PubMed ID: 21558015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
    Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J
    Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress.
    Sekulic-Jablanovic M; Petkovic V; Wright MB; Kucharava K; Huerzeler N; Levano S; Brand Y; Leitmeyer K; Glutz A; Bausch A; Bodmer D
    PLoS One; 2017; 12(11):e0188596. PubMed ID: 29182629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.